Travis Grotz, MD
Surgery · Rochester, MNNPI 1245496934
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Taiho Oncology, Inc. at 32.3% of the total. That places this record below the midpoint for surgery clinicians in MN, where the typical reported total is $1,373.
Across 7 payments — averaging $71.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Taiho Oncology, Inc.$162
- Intuitive Surgical$116
- Medtronic$113
- AstraZeneca$110
Across 7 payments — averaging $116,763 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Iovance Biotherapeutics, Inc.$651K
- Clinigen, Inc.$167K
What the payments were for
- Speaking & faculty fees$20842%
- Travel & lodging$6413%
- Food & beverage$22946%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Taiho Oncology, Inc. | 2 | $162 |
| Intuitive Surgical | 2 | $116 |
| Medtronic | 1 | $113 |
| AstraZeneca | 2 | $110 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRANSORB$113
How this compares
$501 in reported general payments places this provider in the 30th percentile of 498 surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 22 | $112 |
| Metronidazole | 21 | $27 |
| Ondansetron Hcl | 15 | $20 |
Paid to pharmacies, not to this prescriber.
Other surgery in Rochester
- Todd KelloggRochester$110K
- Sean ClearyRochester$107K
- Omar GhanemRochester$42K
- Charlotte HorneRochester$37K
- Megan NelsonRochester$20K
- Susanne WarnerRochester$20K
- Cornelius ThielsRochester$17K
- Daniel StephensRochester$16K
- Jeffrey JohnsonRochester$13K
- Jayson DockShakopee$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.